While there are limitations, the promise of improved diabetes management, cardiovascular benefits, and new formulations places GLP-1 agonists at the forefront of diabetes care
Baseline laboratory investigations are recommended to assess liver function, kidney function, oxidative stress markers, and nutritional deficiencies prior to initiating therapy
Int J Obes (Lond) 2009
However, as the GLP-1 albumin fusion and unfused albumin have the same theoretical pI, and only small differences in pH-dependent net charge, this probably does not explain the discrepancy between their FcRn binding properties and cellular handling or plasma half-life
The choice of GLP-1 medication depends on individual factors, and patients are advised to discuss their options with healthcare providers to create personalized treatment plans that effectively manage their condition
Our team will monitor your progress and adjust your treatment plan as needed to ensure youre achieving the best possible results
